Cargando…
Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy
Mesenchymal stem cells (MSCs) are a promising cellular vehicle for transferring anti-cancer factors to malignant tumors. Currently, a variety of anti-cancer agents, including the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), have been loaded into MSCs derived from a range of...
Autores principales: | Wang, Zujia, Chen, Hongting, Wang, Peiyun, Zhou, Miaojin, Li, Guangxu, Hu, Zhiqing, Hu, Qian, Zhao, Junya, Liu, Xionghao, Wu, Lingqian, Liang, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968737/ https://www.ncbi.nlm.nih.gov/pubmed/35267023 http://dx.doi.org/10.1093/stcltm/szab031 |
Ejemplares similares
-
Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes
por: Peters, Marijn C, et al.
Publicado: (2022) -
A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
por: Schweizer, Michael T., et al.
Publicado: (2019) -
Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor
por: Mittal, Sharad K., et al.
Publicado: (2019) -
Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension
por: Sharma, Mayank, et al.
Publicado: (2022) -
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
por: Boberg, Erik, et al.
Publicado: (2020)